THE MAST CELL DISEASE SOCIETY INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$988,433
Cash & Equivalents
>99%
Receivables (Non-Related)
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$28,097
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$994,862
$984,860
-1%
Receivables (Non-Related)
$97,909
$3,000
-97%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$2,683
$573
-79%
Investments
-
-
-
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$1,095,454
$988,433
-10%
Liabilities
2023
2024
Change
Payables & Accruals
$32,214
$28,097
-13%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$32,214
$28,097
-13%
Net assets
2023
2024
Change
Restricted Net Assets
$221,933
$168,925
-24%
Unrestricted Net Assets
$841,307
$791,411
-6%
Net assets
2023
2024
Change
Net assets
+$1,063,240
+$960,336
-10%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)